A Novel Solution For A Novel Virus: Leading Biotech CEO Dr. Vipin Garg Of Altimmune

In this episode, we chat with Dr. Vipin Garg, the President and CEO of Altimmune, a biotech company pioneering the development of intranasal vaccines and therapeutics, including ones that can prevent the transmission of and treat COVID.

He has more than three decades of experience in the biotechnology and pharmaceutical industries with a successful track record building and leading notable private and publicly traded companies.

Dr. Garg was named a Top 25 Biotech CEO of 2021 by The Healthcare Technology Report.  He received his PhD in Biochemistry in 1982 from the University of Adelaide, Australia, and his Master of Science degree from IARI Nuclear Research.

We hope you enjoy the show.

Listen on iTunes or Google Podcasts.

Insights & Capital

Discover unique insights from leading executives and growth investors.

Sign up for our weekly newsletter.

Top Go Back
© 2020 GrowthCap, LLC. All rights reserved.

Sign up for GrowthCap Insights